However, some conditions such as proliferative diabetic retinopathy (PDR) or wet age-related macular degeneration (AMD) might benefit from a simultaneous blocking of VEGF-A, VEGF-C, and VEGF-D, if anti-VEGF-A therapy alone appears insufficient [49]. Here, VEGFC is linked to wet macular degeneration.